Lamivudine 300 mg in HIV infection: dose change. Once-a-day dosing.
Lamivudine is now available as 300 mg tablets for once-a-day treatment of HIV-infected adults. In HIV-infected adults, 300 mg lamivudine in a single daily dose has similar efficacy to 150 mg lamivudine in two daily doses. The 300-mg tablets may make treatment more convenient.
D000328:Adult; D002648:Child; D004359:Drug Therapy, Combination; D005602:France; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D019469:Indinavir / Q000627:therapeutic use; D019259:Lamivudine / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D019888:Nelfinavir / Q000627:therapeutic use; D011480:Protease Inhibitors / Q000627:therapeutic use; D018894:Reverse Transcriptase Inhibitors / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D018119:Stavudine / Q000627:therapeutic use; D015215:Zidovudine / Q000627:therapeutic use
D011480:Protease Inhibitors; D018894:Reverse Transcriptase Inhibitors; D019259:Lamivudine; D015215:Zidovudine; D019469:Indinavir; D018119:Stavudine; D019888:Nelfinavir